FLT3 and acute myeloid leukemia: With regard to AML, Yang et al. (2014) demonstrated that cytokines released by stromal cells mediate resistance to FLT3‐TKIs such as quizartinib, although the involved cytokines were not identified (Yang et al., 2014).